Balasa Dinverno & Foltz LLC Organon & Co. Transaction History

Balasa Dinverno & Foltz LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$31.66 - $38.9 $121,352 - $149,103	-3,833 Reduced 27.72%	9,996 $337,000
Q1 2022 Apr 25, 2022	SELL	$30.45 - $39.36 $360,253 - $465,668	-11,831 Reduced 46.11%	13,829 $483,000
Q4 2021 Jan 26, 2022	SELL	$28.67 - $37.13 $62,643 - $81,129	-2,185 Reduced 7.85%	25,660 $781,000
Q3 2021 Oct 26, 2021	BUY	$28.63 - $35.64 $797,202 - $992,395	27,845 New	27,845 $913,000

792

203M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.96B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Balasa Dinverno & Foltz LLC, based on Form 13F filings with the SEC.

Stay updated on Balasa Dinverno & Foltz LLC with notifications on news.